10/29/2024
4:01 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
1:12 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
7:06 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
3:42 PM | BML Investment Partners, L.P. (Filed by)
Oramed Pharmaceuticals (Subject)
| Form SC 13G | |
06/26/2024
8:00 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2024
8:00 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:15 PM | Gabay Avraham (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/20/2024
6:32 AM | Oramed Pharmaceuticals (Filer)
| Form ARS | |
06/20/2024
6:30 AM | Oramed Pharmaceuticals (Filer)
| Form DEF 14A | |
06/10/2024
4:28 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
4:15 PM | Oramed Pharmaceuticals (Issuer)
Reznick Yehuda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:00 PM | Oramed Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
8:00 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
7:07 PM | Oramed Pharmaceuticals (Issuer)
Reznick Yehuda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:30 PM | Oramed Pharmaceuticals (Issuer)
Reznick Yehuda (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/22/2024
8:30 PM | KIDRON NADAV (Filed by)
Oramed Pharmaceuticals (Subject)
| Form SC 13D | |
03/19/2024
7:00 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
4:15 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:00 PM | Oramed Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2024
7:42 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
7:42 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
4:30 PM | Aghion Daniel (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
3:45 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
3:45 PM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
3:36 PM | Oramed Pharmaceuticals (Issuer)
Rozov Yadin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:37 PM | Oramed Pharmaceuticals (Issuer)
Sank Leonard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:39 PM | Oramed Pharmaceuticals (Issuer)
Silberman David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:40 PM | Hexter Joshua (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:41 PM | KIDRON NADAV (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:43 PM | Kidron Miriam (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:32 PM | Oramed Pharmaceuticals (Issuer)
Shapiro Benjamin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:33 PM | Aghion Daniel (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:34 PM | Mayer Arie (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
12:13 PM | Aghion Daniel (Reporting)
Oramed Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/21/2023
8:26 AM | Oramed Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
